State-of-the-Art Tools and Technologies
Boehringer Ingelheim's successful drug discovery relies on excellent interdisciplinary cooperation and well-functioning medicinal chemistry with state-of-the-art tools, e.g. chemo-informatics or efficient biopharmaceutical development. The platform for our drug discovery is comprised of technologies such as e-R&D, high throughput screening (HTS) or novel biological entities.
Technologies
-
Global Skill CentersTo further strengthen the R&D organisation, Global Skill Centers (GSC) improve efficiency and secure equal access to state-of-the-art technologies and informatics platforms for all R&D sites. read more
-
Technology AlliancesComplementing our in-house R&D efforts, our partnering activities are also key to success in developing tomorrow's cures from today's science. read more
